Keya Medical
About Keya Medical
Keya Medical is an international medical technology company at the forefront of developing deep learning-based medical devices for disease diagnosis and treatment. The company specializes in AI-driven solutions, particularly for cardiovascular diagnosis, aiming to empower clinicians with advanced technologies that address real-world challenges. Its flagship product, DEEPVESSEL FFR, is an FDA-cleared, CE-marked, NMPA-approved, and HSA (Singapore) certified CT-FFR analysis tool. This software provides a non-invasive physiological functional assessment of coronary arteries using coronary computed tomography angiography (CCTA), generating a 3D interactive model and a comprehensive PDF report to aid in decision-making for patient care.
Keya Medical’s solutions are designed to improve the triage of patients with chest pain and suspected coronary artery disease (CAD) by offering accurate, efficient, and cost-effective diagnostic assessments. The company collaborates with medical centers and key opinion leaders globally, applying advancements in machine learning, medical informatics, and regulatory science. Beyond cardiology, Keya Medical is also developing deep learning-based medical devices across various specialties, including neurology, pulmonology, pathology, and surgery.
Focus Areas
Business Intelligence
| Key Investors | GGV Capital, Kunlun Internet Intelligent Industrial Investment Fund, Shanghai Guofang FOF, Shanghai International Group (SIG), Alwin Capital, IDG Capital, GL Ventures, GIC, Qiming Venture Partners, Boyu Capital, Beijing Kunlun Tech, Source Code Capital, Tasly Group, CICC Capital, Shanghai Artificial Intelligence Investment Fund, Qianhai Gaozu Asset Management Fund, IN CAPITAL |
| Partnerships | Precision Image Analysis (PIA), Corazon Imaging, Qinnovativ Medtech, Kanbai Tech, Bayer, CARPL.ai, Zwanger-Pesiri Radiology |
| Technology | Deep learning algorithms, deep learning neural networks, computer vision, medical image analysis, cloud-based (Ambra Intelerad's AWS platforms) |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
For physicians, Keya Medical's solutions, particularly DEEPVESSEL FFR, offer a precise, non-invasive, and efficient method for evaluating coronary artery disease. This can significantly enhance diagnostic accuracy, guide revascularization decisions, and reduce the need for unnecessary invasive procedures. The comprehensive anatomical and functional information provided at every point of the coronary tree allows for a more complete understanding of patient conditions. The streamlined workflow, without the need for scanner certification or extensive staff training, integrates easily into existing practices. Furthermore, the new Category I CPT code (75580) for non-invasive FFR estimates from CCTA software analysis supports reimbursement, making these advanced diagnostics more accessible and financially viable.
Keya Medical's solutions are designed for integration into clinical workflows. Their CardiSight workflow is an AI suite that integrates CCTA interpretation with DeepVessel FFR and DeepVessel Plaque analysis for a comprehensive understanding of coronary pathology. They also collaborate with partners like Precision Image Analysis (PIA) for cloud-based, on-demand post-processing services and Corazon Imaging for mobile radiology services, enabling flexible and accessible deployment of their AI FFR CT solutions.
What the Web Says
Keya Medical is an international medical technology company specializing in deep learning-based medical devices for disease diagnosis and treatment, particularly in cardiology. Their flagship products, DeepVessel FFR and DeepVessel Plaque, are AI-powered software solutions for analyzing coronary CT angiography (CCTA) images to assess coronary artery disease. Reviews for their products are generally positive, highlighting their accuracy and user-friendliness. However, employer reviews indicate a mixed sentiment, with some employees feeling overworked and underpaid.
Overall: MixedStrengths
- Reliable and user-friendly AI CT-FFR solution (DeepVessel FFR).
- Provides enhanced understanding of stenosis and flow issues through 3D models.
- Exceptional accuracy and reliability of results, aiding in informed clinical decisions.
- Advanced AI capabilities offer deeper understanding of vessel anatomy.
- DeepVessel FFR has demonstrated higher accuracy than other non-invasive tests.
- DeepVessel Plaque offers comprehensive quantitative measurements for coronary plaque analysis.
Limitations
- Some employees report being overworked, underpaid, and under-appreciated.
- Potential for the company not to be a long-term home for employees.
- One review for a related company, Keya, Inc., mentioned no advancement opportunities.
Based on reviews from: KeyaMedical (Testimonials), Indeed.com, AuntMinnie, Diagnostic Imaging, Capterra
Last updated: 2026-07-19
Videos
News, demos, and interviews about Keya Medical.
Videos load interactively. If none appear, search YouTube for Keya Medical →
Press & Coverage
Frequently Asked Questions
Related Companies
Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]
Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]
Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]
Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]
Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]
SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]